Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
114 Leser
Artikel bewerten:
(0)

Lazare Kaplan International, Inc.

NEW YORK, Jan. 5 /PRNewswire-FirstCall/ -- Lazare Kaplan International Inc. (the "Company") announced today that, in connection with its efforts to resolve the material uncertainties preventing it from timely filing its periodic reports under the Securities Exchange Act of 1934 ("Exchange Act"), the Company filed claims under certain of its insurance policies (the "Insurance Policies"). Discussions of such material uncertainties have been previously disclosed by the Company on its Forms 8-K filed with the Securities and Exchange Commission on September 1, 2009, September 16, 2009, October 8, 2009 and October 21, 2009.

On January 2, 2010, in connection with such claims, the Company and certain insurers of the Company and underwriters (collectively, the "Underwriters") of the Insurance Policies, entered into an Agreement for Interim Payment (the "Agreement"). Pursuant to the Agreement, the Underwriters agree to pay to the Company, prior to conclusion of their claim investigation, (a) an interim payment of $28 million pursuant to claims made by the Company under the Insurance Policies, and (b) the Company's "sue and labor" costs and expenses. Except with respect to any rights of subrogation, the Underwriters waive and release any right to recover the interim payment, directly or indirectly by any means, from the Company either by way of offset, setoff, recoupment, counterclaim or otherwise. In return, the Company waives all rights at law, equity or otherwise to pursue claims for consequential, extra-contractual or tort-like claims against the Underwriters in their capacity as having subscribed to the Insurance Policies, and agrees to pursue only such indemnity under the Insurance Policies that provably exceeds the interim payment. The Company is continuing to discuss with the Underwriters claims that it believes provably exceed such interim payment. Pursuant to the Agreement, the Underwriters have committed to reach a decision by May 3, 2010 as to whether the Company has coverage under the Insurance Policies with respect to the claims and, if so, the amount of payment for the same.

The interim payment by itself does not resolve the material uncertainties, and the Company is continuing to pursue final resolution thereof through its remaining claims under the Insurance Policies as well as other strategies.

The Company also announced today the following: $25.0 Million Facility

On February 19, 2008, Lazare Kaplan Belgium NV, a subsidiary of the Company (the "Subsidiary"), and Antwerp Diamond Bank NV ("ADB") entered into a Credit Confirmation Letter (the "Credit Letter"), pursuant to which ADB granted to the Subsidiary an uncommitted US$25 million credit facility (the "$25M Facility"). The Subsidiary previously used the $25M Facility from time to time for working capital purposes; however, as of December 29, 2009, there were no amounts outstanding under the $25M Facility.

On December 29, 2009, ADB delivered a notice to the Subsidiary, stating that in accordance with the terms of the Credit Letter, it is terminating the $25M Facility as of January 28, 2010. There are no material early termination penalties to be incurred by the Company or the Subsidiary as a result of the termination of the Facility.

$45.0 Million Facility

On February 20, 2008, the Company and ADB entered into a Credit Confirmation Agreement (the "Credit Agreement"), pursuant to which ADB granted to the Company an uncommitted US$45 million credit facility (the "$45M Facility"). The Company uses the $45M Facility for working capital purposes. As of December 30, 2009, approximately $43 million was reflected as outstanding under the $45M Facility by ADB.

On December 30, 2009, ADB delivered a notice to the Company, stating that in accordance with the terms of the Credit Agreement, it is terminating the $45M Facility on March 1, 2010. Pursuant to such notice, ADB is claiming that the outstanding principal balance due and owing under the $45M Facility, as set forth above, plus accrued and unpaid interest, costs, charges and fees (including attorneys' fees) shall be due and payable on such termination date, which aggregate amount the Company has not as of yet ascertained.

The Company sharply disputes ADB's claim that it has the right under the Credit Agreement to terminate the $45M Facility at this time. The Company believes that it has material defenses and counterclaims to any legal action that might be filed by ADB on the basis of the asserted termination. The Company expects to be in discussions with ADB to amicably resolve these matters, of which there can be no assurance of success.

AMEX Listing

On December 31, 2009, the Company submitted to NYSE Regulation (the "Staff"), on behalf of NYSE AMEX LLC (the "Exchange"), a supplement to its Plan of Compliance originally submitted to the Staff on October 7, 2009, requesting an extension of the Exchange's delisting deadline to May 31, 2010, which would give the Company the time it believes necessary to prepare and file all delinquent Exchange Act reports. The Staff is currently reviewing the request.

Lazare Kaplan International, Inc. sells its diamonds and jewelry products through a worldwide distribution network. The Company is noted for its ideal cut diamonds, which it markets internationally under the brand name, Lazare Diamonds®.

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. Those risks include a softening of retailer or consumer acceptance of, or demand for, the Company's products, pricing pressures, adequate supply of rough diamonds, liquidity, and other competitive factors. The information contained in this press release is accurate only as of the date issued. Investors should not assume that the statements made in these documents remain operative at a later time. Lazare Kaplan International Inc. undertakes no obligation to update any information contained in this news release.

Lazare Kaplan International Inc.

CONTACT: Edward Nebb, Comm-Counsellors, LLC for Lazare Kaplan
International Inc., +1-203-972-8350

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.